(Q40573450)

English

Enhancement of the antagonistic potency of transforming growth factor-beta receptor extracellular domains by coiled coil-induced homo- and heterodimerization

scientific article published on 24 March 2004

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Enhancement of the antagonistic potency of transforming growth factor-beta receptor extracellular domains by coiled coil-induced homo- and heterodimerization (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

protein heterodimerization activity

1 reference

based on heuristic

inferred from title

Maureen D O'Connor-McCourt

5

object named as

Maureen D O'Connor-McCourt

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Gregory De Crescenzo

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Phuong L Pham

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Yves Durocher

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Heman Chao

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

24 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

279

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

26013-26018

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

Betaglycan presents ligand to the TGF beta signaling receptor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

Mapping of the ligand binding domain of the transforming growth factor beta receptor type III by deletion mutagenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

Cytokines in kidney disease: the role of transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

TGF-beta signaling: positive and negative effects on tumorigenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

Chimeric extracellular domain type II transforming growth factor (TGF)-beta receptor fused to the Fc region of human immunoglobulin as a TGF-beta antagonist

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400655200

21 January 2018

Identifiers

10.1074/JBC.M400655200

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40573450&oldid=1903204586"